[Characterization of hypotonia-hyporesponsiveness after pentavalent vaccine and neurodevelopmental screening in children under 6 years of age, 2013-2018, Uruguay].

Caracterización de la hipotonía-hiporrespuesta post vacuna pentavalente y tamizaje del neurodesarrollo en niños bajo 6 años de edad, 2013-2018, Uruguay.

Journal

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia
ISSN: 0717-6341
Titre abrégé: Rev Chilena Infectol
Pays: Chile
ID NLM: 9305754

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 16 07 2020
accepted: 23 02 2021
entrez: 29 6 2021
pubmed: 30 6 2021
medline: 27 7 2021
Statut: ppublish

Résumé

Hypotonic-hyporesponsive episodes (HHE) is one frequently reported neurologic adverse effect supposedly attributable to vaccination and immunization. Its long-term impact on neurodevelopment is not completely known. To characterize the post-pentavalent vaccine HHE events reported to the Uruguayan Ministry of Health (M of H) between 2014 and 2018. To perform neurodevelopment screening of those who were under 6 years of age at the time of evaluation. Descriptive study of the reports made to the National Farmacosurveillance System of the M of H. Neurodevelopment screening was performed using the National Guidelines for Developmental Surveillance. 30 cases were studied. Most cases occurred after the first doses, were of short duration and during the first hours after vaccination, with spontaneous recovery. Median time between the event and this evaluation was 2 years and 2 months. Screening tests were normal in 15. Delay in the language area was detected in one case. HHE events had similar characteristics to those described in the literature, with no severe short-term complications. Despite the limitations of the present study, no delays nor deviations were found in the development of the children who were evaluated.

Sections du résumé

BACKGROUND BACKGROUND
Hypotonic-hyporesponsive episodes (HHE) is one frequently reported neurologic adverse effect supposedly attributable to vaccination and immunization. Its long-term impact on neurodevelopment is not completely known.
AIM OBJECTIVE
To characterize the post-pentavalent vaccine HHE events reported to the Uruguayan Ministry of Health (M of H) between 2014 and 2018. To perform neurodevelopment screening of those who were under 6 years of age at the time of evaluation.
METHODS METHODS
Descriptive study of the reports made to the National Farmacosurveillance System of the M of H. Neurodevelopment screening was performed using the National Guidelines for Developmental Surveillance.
RESULTS RESULTS
30 cases were studied. Most cases occurred after the first doses, were of short duration and during the first hours after vaccination, with spontaneous recovery. Median time between the event and this evaluation was 2 years and 2 months. Screening tests were normal in 15. Delay in the language area was detected in one case.
CONCLUSIONS CONCLUSIONS
HHE events had similar characteristics to those described in the literature, with no severe short-term complications. Despite the limitations of the present study, no delays nor deviations were found in the development of the children who were evaluated.

Identifiants

pubmed: 34184713
pii: S0716-10182021000200218
doi: 10.4067/S0716-10182021000200218
pii:
doi:

Substances chimiques

Vaccines, Combined 0

Types de publication

Journal Article

Langues

spa

Sous-ensembles de citation

IM

Pagination

218-223

Auteurs

Carlos Zunino (C)

Departamento de Pediatría, Facultad de Medicina, Universidad de la República, Uruguay.

Noelia Speranza (N)

Departamento Farmacología y Terapéutica, Facultad de Medicina, Universidad de la República, Uruguay.

Helena Deutsch (H)

Facultad de Medicina, Universidad de la República, Uruguay.

Ricardo Mora (R)

Facultad de Medicina, Universidad de la República, Uruguay.

Cecilia Rebellato (C)

Facultad de Medicina, Universidad de la República, Uruguay.

Gabriela Cuello (G)

Facultad de Medicina, Universidad de la República, Uruguay.

Maite Inthamoussu (M)

Departamento Farmacología y Terapéutica, Facultad de Medicina, Universidad de la República, Uruguay.

Gustavo Giachetto (G)

Departamento de Pediatría, Facultad de Medicina, Universidad de la República, Uruguay.

Teresa Picón (T)

Programa Nacional de Vacunaciones, Ministerio de Salud Pública, Uruguay.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH